ManTech Launches “Career Enablement” to Accelerate Employee Advancement
HERNDON, Va., Feb. 20, 2020 (GLOBE NEWSWIRE) — ManTech (Nasdaq: MANT) today launches a new “Career Enablement” program that will […]
resTORbio to Present at the 9th Annual Leerink Partners Global Healthcare Conference
BOSTON, Feb. 20, 2020 (GLOBE NEWSWIRE) — resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target […]
Alimera Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020 and Provide Corporate Update
ATLANTA, Feb. 20, 2020 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development […]
miRagen Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on March 11, 2020
BOULDER, Colo., Feb. 20, 2020 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the […]
Genocea to Present at the SVB Leerink 9th Annual Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, […]
MyoKardia to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 27, 2020
BRISBANE, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), today announced that it will report fourth quarter […]
Mobileye and Pointer Collaborate to Install Traffic Telematics Units on Traffic Lights in Jerusalem
WOODCLIFF LAKE, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) — PowerFleet, Inc. (NASDAQ: PWFL), a global leader and provider of subscription-based […]
Fulgent Genetics to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday March 10, 2020
TEMPLE CITY, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today […]
CytomX Therapeutics to Announce Fourth Quarter 2019 Financial Results
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company […]
GBT Accepting Proposals for 2020 ACCEL Grants to Support Novel Access-to-Care Programs for People Living with Sickle Cell Disease
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it […]
